Staels B - Search Results

1

The Sodium-Glucose Cotransporter 2 Inhibitor Dapagliflozin Prevents Cardiomyopathy in a Diabetic Lipodystrophic Mouse Model.

Joubert M, Jagu B, Montaigne D, Marechal X, Tesse A, Ayer A, Dollet L, Le May C, Toumaniantz G, Manrique A, Charpentier F, Staels B, Magré J, Cariou B, Prieur X. Joubert M, et al. Among authors: staels b. Diabetes. 2017 Apr;66(4):1030-1040. doi: 10.2337/db16-0733. Epub 2017 Jan 4. Diabetes. 2017. PMID: 28052965

2

Glucose regulates the expression of the farnesoid X receptor in liver.

Duran-Sandoval D, Mautino G, Martin G, Percevault F, Barbier O, Fruchart JC, Kuipers F, Staels B. Duran-Sandoval D, et al. Among authors: staels b. Diabetes. 2004 Apr;53(4):890-8. doi: 10.2337/diabetes.53.4.890. Diabetes. 2004. PMID: 15047603

3

Peroxisome proliferator-activated receptor alpha induces NADPH oxidase activity in macrophages, leading to the generation of LDL with PPAR-alpha activation properties.

Teissier E, Nohara A, Chinetti G, Paumelle R, Cariou B, Fruchart JC, Brandes RP, Shah A, Staels B. Teissier E, et al. Among authors: staels b. Circ Res. 2004 Dec 10;95(12):1174-82. doi: 10.1161/01.RES.0000150594.95988.45. Epub 2004 Nov 11. Circ Res. 2004. PMID: 15539630

4

Farnesoid X receptor: a new player in glucose metabolism?

Cariou B, Duran-Sandoval D, Kuipers F, Staels B. Cariou B, et al. Among authors: staels b. Endocrinology. 2005 Mar;146(3):981-3. doi: 10.1210/en.2004-1595. Endocrinology. 2005. PMID: 15713939 No abstract available.

5

Potential regulatory role of the farnesoid X receptor in the metabolic syndrome.

Duran-Sandoval D, Cariou B, Fruchart JC, Staels B. Duran-Sandoval D, et al. Among authors: staels b. Biochimie. 2005 Jan;87(1):93-8. doi: 10.1016/j.biochi.2004.11.018. Biochimie. 2005. PMID: 15733743 Review.

6

The farnesoid X receptor modulates hepatic carbohydrate metabolism during the fasting-refeeding transition.

Duran-Sandoval D, Cariou B, Percevault F, Hennuyer N, Grefhorst A, van Dijk TH, Gonzalez FJ, Fruchart JC, Kuipers F, Staels B. Duran-Sandoval D, et al. Among authors: staels b. J Biol Chem. 2005 Aug 19;280(33):29971-9. doi: 10.1074/jbc.M501931200. Epub 2005 May 16. J Biol Chem. 2005. PMID: 15899888 Free article.

7

Therapeutic roles of peroxisome proliferator-activated receptor agonists.

Staels B, Fruchart JC. Staels B, et al. Diabetes. 2005 Aug;54(8):2460-70. doi: 10.2337/diabetes.54.8.2460. Diabetes. 2005. PMID: 16046315 Review.

8

Hepatic PCSK9 expression is regulated by nutritional status via insulin and sterol regulatory element-binding protein 1c.

Costet P, Cariou B, Lambert G, Lalanne F, Lardeux B, Jarnoux AL, Grefhorst A, Staels B, Krempf M. Costet P, et al. Among authors: staels b. J Biol Chem. 2006 Mar 10;281(10):6211-8. doi: 10.1074/jbc.M508582200. Epub 2006 Jan 6. J Biol Chem. 2006. PMID: 16407292 Free article.

9

The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice.

Cariou B, van Harmelen K, Duran-Sandoval D, van Dijk TH, Grefhorst A, Abdelkarim M, Caron S, Torpier G, Fruchart JC, Gonzalez FJ, Kuipers F, Staels B. Cariou B, et al. Among authors: staels b. J Biol Chem. 2006 Apr 21;281(16):11039-49. doi: 10.1074/jbc.M510258200. Epub 2006 Jan 30. J Biol Chem. 2006. PMID: 16446356 Free article.

10

The expanding role of the bile acid receptor FXR in the small intestine.

Cariou B, Staels B. Cariou B, et al. Among authors: staels b. J Hepatol. 2006 Jun;44(6):1213-5. doi: 10.1016/j.jhep.2006.03.006. Epub 2006 Apr 7. J Hepatol. 2006. PMID: 16618512 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

792 results

Search Page